MCRB
Seres Therapeutics Inc
2.90$
+1.8%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 0.00 | 0.00 | 10.92 | 15.87 | 13.88 | 12.18 | 8.33 | 31.61 | 1.32 | 19.74 | 0.00 | 0.09 | |
| – | – | 5.50 | 0.62 | 41.15 | 44.23 | 47.10 | 28.29 | 22.70 | 30.95 | 0.19 | 3.02 | 0.45 | 0.47 | |
| – | – | -5.50 | -0.62 | -30.23 | -28.36 | 13.88 | 12.18 | -14.38 | 31.61 | 1.13 | -3.02 | -0.45 | -0.38 | |
| 1.07 | 2.47 | 5.50 | 32.38 | 41.15 | 44.23 | 47.10 | 28.29 | 22.70 | 30.95 | 20.29 | 18.37 | 8.31 | 5.53 | |
| 0.49 | 0.64 | 2.24 | 14.25 | 16.37 | 16.83 | 16.00 | 8.74 | 7.71 | 15.11 | 13.00 | 12.11 | 6.84 | 4.41 | |
| 1.56 | 3.11 | 7.74 | 46.62 | 57.52 | 61.06 | 63.10 | 37.56 | 7.71 | 45.67 | 33.29 | 27.46 | 15.16 | 10.22 | |
| -1.56 | -3.11 | -7.74 | -46.62 | -46.60 | -45.19 | -49.23 | -25.38 | -22.09 | -14.07 | -33.29 | -30.48 | -15.61 | -10.59 | |
| 0.00 | 0.02 | 0.00 | 0.47 | 0.49 | 0.79 | 0.58 | 0.18 | 0.73 | 0.63 | 1.11 | 2.06 | 0.00 | 0.00 | |
| -1.61 | -3.13 | -8.58 | -46.56 | -45.97 | -44.19 | -48.57 | -24.81 | -22.34 | -14.30 | -33.97 | -29.71 | -16.19 | 0.64 | |
| – | 0.02 | 0.84 | -0.68 | 1.12 | -0.79 | 0.66 | -2.13 | -0.67 | -0.89 | 0.68 | 2.34 | 0.02 | – | |
| -1.61 | -3.13 | -8.58 | -46.56 | -45.97 | -44.19 | -48.57 | -24.81 | -22.34 | -14.30 | -46.29 | -17.77 | -18.86 | 0.64 | |
| -1.54 | -3.06 | -7.65 | -46.00 | -44.49 | -40.60 | -45.37 | -21.95 | -19.38 | -12.37 | -31.63 | -28.35 | -15.48 | 1.11 |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.